← All stocks

Integer Holdings Corp

ITGR Net selling
CIK 0001114483 #1476 in the set updated 17 Sep 2026
Bought (120 mo)
$1.65M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$101.84M
$0.00 on a plan · $87.04M straight out of an exercise
Sold at will
$14.80M
49 of 123 sales
Net
−$100.19M
−$13.15M against sales at will

By person

43 insiders · 152 transactions
12.2×

Payman Khales holds 12.2 times base salary in stock. $7.81M of shares against $637.02K in salary for 2025.

Salary from the company's own proxy. The shares are what Payman Khales last reported holding, valued at $126.23, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dziedzic Joseph W
President & CEO
$746.12K (4)
$41.89M (4) scheduled
−$41.15M
45,807
0.1348%
$5.78M
+500.6%
HOOK THOMAS J
President & CEO
$11.10M (9) scheduled
−$11.10M
242,305
0.7128%
$30.59M
0.0%
Spence Donald J
Director
$6.63M (6) scheduled
−$6.63M
18,781
0.0553%
$2.37M
+78.2%
SANFORD BILL R
Director
$5.30M (9) scheduled
−$5.30M
47,322
0.1392%
$5.97M
+75.1%
SUMMERS WILLIAM B JR
Director
$4.75M (8) scheduled
−$4.75M
44,410
0.1306%
$5.61M
+16.2%
Friedman Jeremy
EVP, COO
$4.44M (12) scheduled
−$4.44M
16,514
0.0486%
$2.08M
+668.8%
Thor Kirk K
Chief Human Resources Officer
$3.98M (2)
−$3.98M
7,153
0.0210%
$902.89K
BAILEY PAMELA G
Director
$2.89M (8) scheduled
−$2.89M
54,253
0.1596%
$6.85M
+63.4%
Hobby Jean M.
Director
$2.77M (7) scheduled
−$2.77M
3,794
0.0112%
$478.90K
+703.8%
Bolt Jennifer M
EVP, Global Operations & ESG
$2.29M (7) scheduled
−$2.29M
25,313
0.0745%
$3.20M
+125.8%
McEvoy Timothy G
Sr. VP, Gen. Counsel & Sec.
$1.96M (4) scheduled
−$1.96M
33,345
0.0981%
$4.21M
+11.7%
Flanagan Joseph F
EVP, Quality & Regulatory Affa
$1.91M (4) scheduled
−$1.91M
12,680
0.0373%
$1.60M
+3,863%
Senn Andrew
President, Growth & Innovation
$1.75M (3)
−$1.75M
5,405
0.0159%
$682.25K
−4.5%
Smyth Declan
Pres., Advanced Surgical, Orth
$1.71M (6) scheduled
−$1.71M
6,766
0.0199%
$854.04K
+189.5%
MAXWELL MARTIN C
Director
$101.26K (1)
$1.61M (6) scheduled
−$1.51M
25,106
0.0739%
$3.17M
+823.7%
Gonzalez Jose Antonio
President, CRM & Neuro
$1.34M (3)
−$1.34M
4,702
0.0138%
$593.51K
−23.8%
MAZZA THOMAS J
VP, Corporate Controller
$1.07M (4) scheduled
−$1.07M
3,123
0.0092%
$394.20K
−85.1%
Hinrichs James F.
Director
$256.76K (1)
$1.18M (1) scheduled
−$919.01K
7,424
0.0218%
$937.10K
Khales Payman
President & CEO
$203.07K (1)
$991.74K (1)
−$788.67K
61,854
0.1820%
$7.81M
Harris John A
President, Glob Ops & Manu Tec
$115.50K (1)
$696.61K (4)
−$581.11K
8,657
0.0255%
$1.09M
Houghton Carter
President, Electrochem
$434.60K (2)
−$434.60K
3,681
0.0108%
$464.64K
Borowicz Anthony W
SVP Strategy,Corp Dev., IR
$427.35K (3)
−$427.35K
21,739
0.0640%
$2.74M
+8.5%
SODERBERG PETER H
Director
$279.12K (2) scheduled
−$279.12K
62,745
0.1846%
$7.92M
+106.5%
Thomas Tommy P
VP, Corporate Controller
$47.62K (1)
$303.14K (3)
−$255.52K
4,381
0.0129%
$552.99K
Haire Gary J
EVP & Chief Financial Officer
$106.97K (2)
−$106.97K
4,411
0.0130%
$556.78K
Capps Cheryl C
Director
$106.72K (1)
+$106.72K
13,669
0.0402%
$1.73M
Smith Diron
EVP, Chief Financial Officer
$74.97K (1)
+$74.97K
12,919
0.0380%
$1.63M
+4,178%
Spencer Michael L
Chief Ethics & Compliance Of
$20.33K (2)
−$20.33K
7,962
0.0234%
$1.01M
+2,130%
Trecker Kristin
Chief Human Resource Officer
$2.95K (1)
−$2.95K
1,757
0.0052%
$221.78K
+17.1%
PASSERINI FILIPPO
Director
31,114
0.0915%
$3.93M
+1,045%
Garland Jason K
EVP, Chief Financial Officer
16,061
0.0472%
$2.03M
Antrum Sheila
Director
12,069
0.0355%
$1.52M
Carthy Margaret
EVP, Qlty & Regulatory Affairs
7,686
0.0226%
$970.17K
+243.4%
Marshall McAlister C II
SVP, Gen Counsel & Secretary
6,830
0.0201%
$862.12K
Stephens Jim
President, CRM & Neuro
5,852
0.0172%
$738.67K
Jeffers Alvin Tyrone
Director
4,552
0.0134%
$574.58K
Kapito Aaron
Director
3,338
0.0098%
$421.30K
+247.4%
COYLE MICHAEL J
Director
3,322
0.0098%
$419.32K
Becker Joel
President, CRM & Neuro
2,701
0.0079%
$340.94K
Blackwood Lindsay K.
SVP, Gen Counsel & Secretary
2,434
0.0072%
$307.23K
Flanagan James Francis
Director
2,377
0.0070%
$300.04K
Giddens Elizabeth
SVP, General Counsel
1,110
0.0033%
$140.11K
Carr Terence
EVP, Qlty & Regulatory Affairs
952
0.0028%
$120.17K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 491
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 74
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 2,354,268
Sales filed before the plan box existed 35
History held since 19 Oct 2016